7TLO

X-ray crystal structure of substrate free cytochrome P450 CYP142A3 from Mycobacterium Marinum

Summary for 7TLO

• Entry DOI: 10.2210/pdb7tlo/pdb
• Descriptor: Cytochrome P450 142A3, PROTOPORPHYRIN IX CONTAINING FE, ACETATE ION, ... (4 entities in total)
• Functional Keywords: substrate free, oxidoreductase
• Biological source: Mycobacterium marinum ATCC BAA-535
• Total number of polymer chains: 2
• Total formula weight: 92253.87

Authors

Ghith, A.,Bruning, J.B.,Bell, S.G. (deposition date: 2022-01-18, release date: 2022-09-14, Last modification date: 2023-10-18)

Primary citation

Ghith, A.,Doherty, D.Z.,Bruning, J.B.,Russell, R.A.,De Voss, J.J.,Bell, S.G.
The Structures of the Steroid Binding CYP142 Cytochrome P450 Enzymes from Mycobacterium ulcerans and Mycobacterium marinum.
Acs Infect Dis., 8:1606-1617, 2022

PubMed Abstract: The steroid binding CYP142 cytochrome P450 enzymes of species are involved in the metabolism of cholesterol and its derivatives. The equivalent enzyme from was studied to compare the degree of functional conservation between members of this CYP family. We compared substrate binding of the CYP142A3 enzymes of and and CYP142A1 from using UV-vis spectroscopy. The catalytic oxidation of cholesterol derivatives by all three enzymes was undertaken. Both CYP142A3 enzymes were structurally characterized by X-ray crystallography. The amino acid sequences of the CYP142A3 enzymes are more similar to CYP142A1 from than CYP142A2 from . Both CYP142A3 enzymes have substrate binding properties, which are more resemblant to CYP142A1 than CYP142A2. The cholest-4-en-3-one-bound X-ray crystal structure of both CYP142A3 enzymes were determined at a resolution of <1.8 Å, revealing the substrate binding mode at a high level of detail. The structures of the cholest-4-en-3-one binding CYP142 enzymes from and demonstrate how the steroid binds in the active site of these enzymes. They provide an explanation for the high selectivity of the enzyme for terminal methyl C-H bond oxidation to form 26-hydroxy derivatives. These enzymes in pathogenic Mycobacterium species are candidates for inhibition. The work here demonstrates that similar drug molecules could target these CYP142 enzymes from different species in order to combat Buruli ulcer or tuberculosis.

PubMed: 35881654
DOI: 10.1021/acsinfecdis.2c00215

Experimental method

X-RAY DIFFRACTION (1.55 Å)